Abstract submissions open:
16 May, 2022

Submission deadline:
01 July, 2022

Notification to authors regarding acceptance:
01 August, 2022

Click here to submit your abstract


The Organising Committee would like to invite submission of abstracts for the SA HEART® CONGRESS 2022: FACE TO FACE : THE CASE FOR HYBRID CARDIOLOGY, to be held at the Sandton Convention Centred from 28 – 30 October 2022. 

Abstracts to be considered for oral or ePoster presentation (please indicate your preference).

Presentation Formats

  • Oral Presentation
  • Poster Presentation (ePoster)

Authors are requested to follow the instructions clearly.


Maximum of 300 words in MS Word.
Font: Arial 10pt.
No graphs, figures, tables, or diagrams permitted.

Language: English (Poorly written abstracts will not be accepted)

Abstracts must contain:

  • The names of all authors (first name and surname)
  • Affiliations of all authors
  • E-mail address of the corresponding author
  • Contact address
  • Contact telephone number
  • The title must define the topic, be concise (excessively long titles may be shortened at the discretion of the organising committee) and contain no abbreviations
  • The text should cover the background/hypothesis, objectives, method, results and conclusion. An adequate description of the methods and results are a prerequisite to be considered. Abstracts must contain results
  • In the text, only standard abbreviations need not be defined. Non-standard abbreviations and acronyms must be defined on first use

Abstracts received after the cut-off date; incomplete abstracts; abstracts without affiliations of all authors, abstracts without full contact details; abstracts in excess of 300 words and abstracts containing figures or tables will not be published.


  • Arrhythmias
  • Basic Sciences
  • Cardiac Imaging
  • Controversies in Cardiovascular Disease
  • Coronary Artery Disease
  • COVID 19 and Heart Disease
  • Heart Failure
  • Hybrid Therapies
  • Paediatric Cardiology
  • Preventative Cardiology
  • Statistics in Clinical Trials
  • Valvular Heart Disease

Provision has been made for ePoster presentations.

Note: All visuals shown must have informed consent. Speakers must declare a conflict of interest before starting their presentations.

Kindly divide your abstract according to the following headings:  

Research Abstract:
Background | Objectives | Method | Results | Conclusion


Abstracts will be reviewed by the Scientific Committee who reserves the right to accept and allocate abstracts for either poster, oral presentation. Presenters will be notified by the 01  August, 2022 if their abstract has been accepted. All presenters of accepted abstracts must be registered as Congress delegates.


The official language of the conference is English. There will be selected oral presentations.


E-Posters to be displayed at the congress on plasma screens within the expo area at the Sandton Convention Centre. 
Full details for the preparation of ePosters will be included in the abstract acceptance letter.


Abstracts (with the author’s permission) will be published in the SA Heart® Journal. The final decision regarding acceptance of the abstract for publication rests with the Editors of the Journal.

Note: Abstracts will be published digitally in the SA Heart® Journal and also on the SA Heart® website.